Genpact Limited
G · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,291 | $1,254 | $1,215 | $1,249 |
| % Growth | 2.9% | 3.3% | -2.7% | – |
| Cost of Goods Sold | $822 | $804 | $786 | $803 |
| Gross Profit | $470 | $450 | $429 | $446 |
| % Margin | 36.4% | 35.9% | 35.3% | 35.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $262 | $266 | $241 | $249 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $16 | $4 | $4 | $6 |
| Operating Expenses | $278 | $271 | $245 | $256 |
| Operating Income | $192 | $179 | $184 | $190 |
| % Margin | 14.8% | 14.3% | 15.1% | 15.2% |
| Other Income/Exp. Net | -$2 | -$3 | -$8 | -$8 |
| Pre-Tax Income | $189 | $177 | $175 | $183 |
| Tax Expense | $44 | $44 | $44 | $41 |
| Net Income | $146 | $133 | $131 | $142 |
| % Margin | 11.3% | 10.6% | 10.8% | 11.4% |
| EPS | 0.84 | 0.76 | 0.75 | 0.8 |
| % Growth | 10.5% | 1.3% | -6.3% | – |
| EPS Diluted | 0.83 | 0.75 | 0.73 | 0.79 |
| Weighted Avg Shares Out | 176 | 175 | 176 | 178 |
| Weighted Avg Shares Out Dil | 176 | 177 | 178 | 180 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $5 | $6 | $10 |
| Interest Expense | $13 | $18 | $18 | $21 |
| Depreciation & Amortization | $27 | $22 | $21 | $24 |
| EBITDA | $229 | $216 | $214 | $228 |
| % Margin | 17.8% | 17.2% | 17.6% | 18.2% |